How portable negative pressure wound therapy systems work, which wounds benefit, and how Healix360-coordinated clinicians manage wound vac therapy safely in the home.
Healix360 supports access to advanced mobile wound care services. Care is coordinated and provided directly by licensed physicians and nurse practitioners experienced in the evaluation and management of chronic and complex wounds, including post-surgical dehiscence, traumatic wounds, pressure injuries, diabetic foot ulcers, and complex abdominal and extremity wounds. From our Glendale, California headquarters, our coordinators serve patients across nine Southern California counties—Los Angeles, Orange, Riverside, San Bernardino, Ventura, Santa Barbara, Kern, San Luis Obispo, and San Diego—and the Las Vegas metropolitan area covering Clark and Nye counties, Nevada. Our intake line is 877-545-1300.
Negative pressure wound therapy (NPWT)—commonly called a wound vac—is defined as the controlled application of subatmospheric pressure to a sealed wound through an open-cell foam or gauze interface, a semi-occlusive drape, and a vacuum pump that removes exudate and infectious material. NPWT accelerates healing in deep, exudative, or complex wounds by removing fluid, reducing edema, increasing blood flow, drawing wound edges together, and promoting granulation tissue formation. Modern portable units make it possible to deliver this hospital-grade therapy safely in private homes, assisted living communities, and skilled nursing facilities throughout the Healix360 service area.
NPWT was first commercialized in the 1990s and is now considered standard of care for many complex wounds. The system creates a sealed environment over the wound bed and applies continuous or intermittent negative pressure—typically between 75 and 125 mmHg below atmospheric pressure. This deceptively simple mechanical setup produces several distinct biological effects that, together, accelerate healing.
NPWT does more than drain a wound. It mechanically remodels the tissue at the cellular level, stimulating granulation while simultaneously controlling exudate and edema.
Not every wound benefits from NPWT. The therapy is most valuable in deep, complex, or highly exudative wounds where standard dressings are overwhelmed or where the goal is rapid granulation before closure or grafting. Healix360-coordinated clinicians use a defined set of criteria to determine appropriateness.
NPWT is powerful, and like any powerful therapy it has clear contraindications. Applying NPWT to the wrong wound can cause bleeding, infection progression, or fistula formation. Healix360-coordinated clinicians screen carefully before initiating therapy.
All commercial NPWT systems share a common architecture, though manufacturers differ in pump features, dressing materials, and canister design. The major components include the wound interface, the drape, the suction tubing, and the pump unit.
Open-cell polyurethane foam, used in V.A.C. systems, is the most common interface and is well suited to deep, irregular wounds because it conforms readily and produces uniform pressure distribution. Polyvinyl alcohol foam is denser and is used near bone, tendon, or graft sites where less aggressive granulation is desired. Antimicrobial gauze interfaces, used in systems like Smith & Nephew's RENASYS, can be useful in shallow or tunneling wounds.
A semi-occlusive transparent drape is applied over the foam and onto a wide margin of intact skin to create the airtight seal. Maintaining this seal is the single most common technical challenge in NPWT, particularly in awkward anatomical locations such as the sacrum, perineum, or amputated digit.
Modern portable pumps weigh under three pounds and run on rechargeable batteries for 10 to 20 hours, allowing patients to remain mobile. Display panels alert the patient and caregiver to seal loss, full canister, low battery, or blockage. The clinician sets the prescribed pressure, the mode (continuous, intermittent, or variable), and the alarm parameters.
The standard prescription for most adult wounds is 125 mmHg of continuous negative pressure with a polyurethane foam interface. Pressure may be lowered to 75 to 100 mmHg for patients with pain, ischemic risk, or fragile tissue. Intermittent and variable pressure modes cycle the negative pressure on and off, which some studies suggest enhances granulation in certain wounds, although patient tolerance is generally lower because of the cyclic sensation. Healix360-coordinated clinicians individualize the prescription based on wound characteristics and patient feedback.
The original NPWT research by Argenta and Morykwas in the 1990s showed that 125 mmHg of negative pressure was the optimal balance between maximum granulation and minimum tissue ischemia. This number remains the default prescription three decades later.
Care is coordinated and provided directly by licensed physicians and nurse practitioners in the patient's home or facility. Initial NPWT setup typically takes 60 to 90 minutes including patient education.
NPWT dressings are typically changed every 48 to 72 hours, with infected wounds at the more frequent end of the range and clean, granulating wounds at the less frequent end. Healix360-coordinated clinicians visit two to three times weekly to perform dressing changes, reassess the wound, and adjust the prescription as healing progresses. Family members and caregivers are taught to monitor the device, empty the canister, manage alarms, and recognize warning signs—but they do not change the dressing itself.
Most NPWT complications are preventable with attentive monitoring. Healix360 intake coordinators provide a 24-hour clinical contact line so patients and caregivers can reach a clinician at any time.
"A wound vac is not a set-it-and-forget-it device. It is an active partnership between the clinician, the patient, and the family. The patients who do best are the ones who feel confident managing the basics between our visits and confident calling us at any hour when something is off." — Healix360 Clinical Team
Abdominal, sternal, and orthopedic surgical wounds that have separated post-operatively are among the most common indications for home NPWT. According to data summarized by AHRQ, NPWT applied to dehisced surgical wounds reduces healing time substantially compared with traditional moist wound care. Healix360-coordinated clinicians often receive referrals from hospital discharge planners specifically to enable safe transition home with NPWT in place.
Deep pressure injuries with significant tissue loss but a viable wound bed often respond well to NPWT once debridement has been completed. The therapy fills the cavity, manages exudate, and accelerates granulation. NPWT is contraindicated in Stage 4 pressure injuries with exposed bone where osteomyelitis has not been excluded.
NPWT is supported by Level I evidence in diabetic foot ulcers, particularly post-amputation wounds. A landmark trial published in Diabetes Care showed significantly higher rates of complete healing with NPWT compared with advanced moist wound therapy in post-surgical diabetic foot wounds. Combination with offloading and infection control is essential.
Medicare Part B covers NPWT as durable medical equipment when specific criteria are met, including documentation of an appropriate wound type, failure of standard therapy where applicable, and the absence of contraindications. Coverage is typically authorized in increments of one month and renewed based on documented progress. Healix360 intake staff coordinate with the DME supplier and verify benefits before initiating therapy.
Most patients with appropriate indications can have a NPWT pump delivered to their home within 24 to 48 hours of authorization, with the first dressing change performed by a Healix360-coordinated clinician on the same or following day.
Successful home NPWT depends as much on patient and family understanding as on clinician technique. The Healix360 educational protocol covers device basics, daily routines, warning signs, and lifestyle considerations.
NPWT is rarely the final therapy. Most wounds graduate from NPWT to a more conventional dressing protocol once the cavity has filled with healthy granulation tissue and the wound is shallow enough for a foam or alginate dressing to manage exudate. In some cases, NPWT is followed by skin substitute application or surgical closure. Healix360-coordinated clinicians plan the transition carefully to maintain healing momentum.
From the first call at 877-545-1300, our intake coordinators gather the wound history, confirm insurance, and schedule an in-home evaluation, typically within 24 to 48 hours. The licensed physician or nurse practitioner assesses appropriateness, obtains DME authorization, coordinates pump delivery, and performs the initial application at the bedside. Visits continue two to three times weekly until the wound has progressed sufficiently to transition to a conventional dressing protocol or alternative advanced therapy.
Newer NPWT systems integrate instillation therapy—periodic delivery of saline or topical antimicrobials into the wound bed—which has shown promise in heavily contaminated and infected wounds. Disposable single-use pumps for closed surgical incisions are increasingly used to prevent dehiscence in high-risk patients. Smart pumps with cloud connectivity can transmit usage data and alerts to clinicians remotely. Healix360-coordinated clinicians evaluate these emerging technologies and adopt those with strong supporting evidence so that patients in Southern California and Las Vegas have access to the most current options.
NPWT applies controlled suction to a sealed wound dressing, which removes exudate, reduces swelling, increases blood flow, and mechanically stimulates granulation tissue formation. The result is faster wound contraction and a healthier wound bed compared with traditional dressings alone. The therapy is particularly effective for deep, exudative, or complex wounds. Most patients see visible reduction in wound depth within one to two weeks of starting therapy.
Modern portable units are remarkably quiet—most produce a soft hum comparable to a small fan. The pump cycles on and off as it maintains pressure, so it is not running constantly. Most patients sleep through the device without difficulty after a brief adjustment period. The pump is designed to be carried in a small shoulder bag and remains discreet under clothing.
NPWT dressings are typically changed every 48 to 72 hours by your Healix360-coordinated clinician. Infected or heavily exudative wounds may require more frequent changes initially, while clean granulating wounds may extend to every third day. The visit schedule is determined at your initial evaluation and adjusted as the wound progresses. Family members and caregivers do not perform the dressing change themselves.
You can disconnect the pump from the dressing for short periods—typically up to two hours—to shower, with the dressing itself sealed to remain waterproof. The clinician will demonstrate the safe disconnection procedure. Bathing in a tub or swimming is not recommended while NPWT is in place. Always reconnect the pump promptly to maintain therapy continuity.
Medicare Part B covers NPWT as durable medical equipment when documented criteria are met, including appropriate wound type and prior failure of conservative therapy where applicable. The pump and supplies are typically authorized in monthly increments and renewed based on documented healing progress. Healix360 intake staff verify benefits and coordinate with the DME supplier before therapy is initiated. Most patients have minimal out-of-pocket cost when criteria are met.
Most alarms indicate seal leak, full canister, or blockage and can be addressed with brief troubleshooting at home. Healix360 provides a 24-hour clinical contact line, and the patient or caregiver receives written instructions covering the most common alarm scenarios at the initial visit. If the alarm cannot be resolved, the device will continue to attempt suction and a clinician will respond promptly. You should never stop NPWT abruptly without clinician guidance.
The duration depends on the wound type, depth, and rate of healing. Most patients use NPWT for two to eight weeks, after which the wound is shallow enough to transition to a conventional dressing or skin substitute. Some complex wounds require longer courses. Your Healix360-coordinated clinician will reassess at every visit and discontinue therapy as soon as the wound no longer benefits from negative pressure.
Most patients report a sensation of tightness or pulling at the wound, which is the foam compressing under negative pressure. Significant pain is uncommon and usually indicates that pressure should be lowered or technique adjusted. Patients with diabetic neuropathy may feel little or nothing at all. Pain that develops or worsens during therapy should always be reported to the Healix360 team at 877-545-1300.
NPWT can be used on wounds with controlled infection but should not be used on wounds with untreated osteomyelitis or active spreading infection. The therapy itself does not eliminate infection—appropriate antibiotics, debridement, and source control remain essential. Healix360-coordinated clinicians evaluate infection status at every visit and modify therapy if signs of worsening infection appear. Some advanced systems offer instillation of topical antimicrobials for heavily contaminated wounds.
Most wounds transition from NPWT to a conventional dressing protocol once the cavity has filled with healthy granulation tissue. Some wounds proceed to skin grafting or skin substitute application to achieve final closure. The Healix360-coordinated clinician plans the transition carefully and continues care until the wound is fully healed. Maintenance strategies such as offloading, compression, or pressure redistribution are then put in place to prevent recurrence.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.